Where does Dragan Grabulovski work?

Dragan Grabulovski is Co-founder and CEO of Araris Biotech and Venture Partner at Pureos Bioventures.

What check size does Dragan Grabulovski write?

Dragan Grabulovski typically writes checks of $100K – $5M.

What companies did Dragan Grabulovski found?

Dragan Grabulovski founded Araris Biotech.

Where did Dragan Grabulovski go to school?

Dragan Grabulovski studied at ETH Zürich (Ph D); Rychenberg Gymnasium, Winterthur (Matura).

Dragan Grabulovski

InvestorFounder

Venture Partner at Pureos Bioventures · Co-founder and CEO at Araris Biotech

Zurich, Switzerland

Writes $100K – $5M checks · typically $1.5M

FoundedAraris Biotech

Find your path to Dragan

165 people in our graph share verified history with Dragan — schools, employers, funds. One of them is your warm intro.

Alex MercandettiunlockedDragan: together at ETH Zürich (2016–2021)

×5Dragan: together at ETH Zürich

×2Dragan: together at Memo Therapeutics

×3Dragan: together at Araris Biotech AG

About

Dragan Grabulovski is Chief Executive Officer of Araris Biotech AG, a subsidiary of Taiho Pharmaceutical acquired in March 2025. He previously co-founded Covagen, which was sold to Johnson & Johnson in 2014. Grabulovski has experience in founding and scaling biotech companies through successful acquisitions.

Co-founder and CEO at Araris Biotech

Intro paths

→

In turn, Dragan can intro founders to Araris Biotech's investors below.

Araris Biotech's investors · 6

b2ventureBerlin · $270K – $5.4M checks Kinled HoldingHong Kong Pureos BioventuresPfäffikon redalpineZug · $108K – $2.2M checks Samsung VenturesSeoul VI PartnersAltendorf · $2.2M – $4.5M checks

Co-founders at Araris Biotech

Philipp SpycherCo-founder and Chief Scientific Officer

Isabella Attinger-TollerCo-founder

Experience

Araris Biotech AG, a wholly owned subsidiary of Taiho PharmaceuticalChief Executive Officercurrent2025 — presentZurich, Switzerland
Pureos BioventuresVenture Partnercurrent2021 — present
Memo Therapeutics AGStrategic Advisorcurrent2021 — present
Memo Therapeutics AGActing Chairman2020 — 2021
Memo Therapeutics AGBoard Member2018 — 2020
Memo Therapeutics AGStrategic Advisor2017 — 2018
TopPharmOwner of pharmacy "TopPharm Apotheke Witikon"current2018 — presentApotheke Witikon
Grabulovski Consulting ServicesCEO and foundercurrent2015 — presentZurich, Switzerland
Araris Biotech AGCo-founder and Chief Executive Officer2023 — 2025Zurich, Switzerland
Araris Biotech AGCo-founder and Chairman2019 — 2024Zurich, Switzerland
Microcaps AGBoard Member2020 — 2023Zurich, Switzerland
BIOMUNEX PHARMACEUTICALSBoard Observer2016 — 2023Greater Paris Metropolitan Region
ETH ZürichStartup Coach2017 — 2023Zurich, Switzerland
Covagen, one of the Janssen Pharmaceutical Companies of Johnson & JohnsonCSO2014 — 2015
CovagenCSO and co-founder2007 — 2014
ETH ZurichPhD Student2004 — 2007
Adler Apotheke & Bahnhof Apotheke WinterthurPharmacist2004

Skills & more

Life Sciences14Biotechnology19Antibodies6Protein Engineering7Drug Discovery15Due Diligence1Consulting4Advisory Boards2Lifesciences10Cancer4Molecular Biology9Cell Biology2

+12 more

In VitroProtein ChemistryCell CultureIn VivoImmunologyBiochemistryCellR&DStrategic PlanningManagementPharmaceutical IndustryResearch and Development (R&D)

Languages English · French · German · Macedonian · Spanish

From Dragan's professional profile.

Colleagues at Pureos Bioventures

Anne Grahl

Associate at Pureos Bioventures

Butrint Aliu

Analyst at Pureos Bioventures

Christian Altorfer

CFO/COO at Pureos Bioventures

Dominik Escher

Managing Partner at Pureos Bioventures

Klaus Breiner

Managing Partner at Pureos Bioventures

Lars Nieba

Venture Partner at Pureos Bioventures

Martin Münchbach

Managing Partner at Pureos Bioventures

Veronica Gambillara Fonck

Partner at Pureos Bioventures

Network5

Anne Grahl

Associate at Pureos Bioventures

Dominik Escher

Managing Partner at Pureos Bioventures

Klaus Breiner

Managing Partner at Pureos Bioventures

Lars Nieba

Venture Partner at Pureos Bioventures

Luigi Costa

Investor at Pureos Bioventures

Investors connected to Dragan in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dragan Grabulovski?: Dragan Grabulovski is Chief Executive Officer of Araris Biotech AG, a subsidiary of Taiho Pharmaceutical acquired in March 2025. He previously co-founded Covagen, which was sold to Johnson & Johnson in 2014. Grabulovski has experience in founding and scaling biotech companies through successful acquisitions.
Where does Dragan Grabulovski work?: Dragan Grabulovski is Co-founder and CEO of Araris Biotech and Venture Partner at Pureos Bioventures.
What check size does Dragan Grabulovski write?: Dragan Grabulovski typically writes checks of $100K – $5M.
What companies did Dragan Grabulovski found?: Dragan Grabulovski founded Araris Biotech.
Where did Dragan Grabulovski go to school?: Dragan Grabulovski studied at ETH Zürich (Ph D); Rychenberg Gymnasium, Winterthur (Matura).

Founder mafias

ETH Zürich mafia196

Also came through, then founded or led a company.

Thomas DübendorferPhDFounded Spontacts +2 Veronica Gambillara FonckEngineerFounded LimmaTech Biologics +1 Dr. Hanspeter FässlerHonorary Councillor Award (Ehrenrat)Founded Gravis Robotics +1 Stephen LakeVisiting ScholarFounded Jetson Home +1 Maximilian MarquartDoktor (Ph.D.)Founded CHOVIVA +1 Nikolay KobyshevDoctor of Science (Dr. sc.)Founded Assaia +1

+ 189 more

Pureos Bioventures mafia4

Also came through, then founded or led a company.

Veronica Gambillara FonckPartnerFounded LimmaTech Biologics +1 Luigi CostaEntrepreneur in ResidenceFounded Noema Pharma Lars NiebaVenture PartnerFounded Engimmune Therapeutics

Same school

Also attended ETH Zürich362

Bastian HasslingerInvestor at Index Ventures Cat WuInvestor at Index Ventures Steve VassalloInvestor at Foundation Capital Helge DaebelPartner, Head of Water at Emerald Technology Ventures Ag Maurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures Ag Christoph FreiPartner, Head of Energy at Emerald Technology Ventures Ag

+ 356 more

Shared employers

Also worked at Memo Therapeutics AG8

Thomas HarthPartner at Ysios Capital Laura ArgelichAssociate at Ysios Capital Michael SidlerFounding Partner at redalpine Hadrien BouchezPartner at Kurma Partners Andreas WüpperManaging Director at Fresenius Medical Care Ventures Butrint AliuAnalyst at Pureos Bioventures

+ 2 more

Also worked at Araris Biotech AG9

Dima KuzminManaging Partner at 4BIO Capital Therese LiechtensteinPartner at 4BIO Capital Brian McVeighVenture Partner, USA at 4BIO Capital Arnd KaltofenManaging Partner at VI Partners Michael SidlerFounding Partner at redalpine Dominik EscherManaging Partner at Pureos Bioventures

+ 3 more

Also worked at ETH Zürich190

Max HeftiInvestment Director - Energy at Emerald Technology Ventures Ag Alex MercandettiInvestment Manager - Energy at Emerald Technology Ventures Ag Michal NatoraSenior Investment Director - Industrial IT & Robotics at Emerald Technology Ventures Ag Michela PudduSenior Investment Manager - Sustainable Materials and Circularity at Emerald Technology Ventures Ag Annina WinklerSenior Investment Manager - Water & AgriFood at Emerald Technology Ventures Ag Manuel Pantelias GarcesOperating Partner at Valor Equity Partners

+ 184 more